nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—Polydipsia—Ifosfamide—germ cell cancer	0.0113	0.0352	CcSEcCtD
Loxapine—Ileus paralytic—Vinblastine—germ cell cancer	0.0112	0.0349	CcSEcCtD
Loxapine—Slurred speech—Cisplatin—germ cell cancer	0.00675	0.021	CcSEcCtD
Loxapine—HTR2A—myenteric nerve plexus—germ cell cancer	0.00666	0.011	CbGeAlD
Loxapine—CHRM5—skin epidermis—germ cell cancer	0.00613	0.0101	CbGeAlD
Loxapine—HTR6—ganglion—germ cell cancer	0.00591	0.00974	CbGeAlD
Loxapine—Numbness—Vinblastine—germ cell cancer	0.00585	0.0182	CcSEcCtD
Loxapine—DRD5—ganglion—germ cell cancer	0.00575	0.00949	CbGeAlD
Loxapine—HTR1B—telencephalic ventricle—germ cell cancer	0.00572	0.00943	CbGeAlD
Loxapine—SLC6A3—telencephalic ventricle—germ cell cancer	0.00568	0.00936	CbGeAlD
Loxapine—Throat tightness—Etoposide—germ cell cancer	0.00563	0.0176	CcSEcCtD
Loxapine—Sensory loss—Vinblastine—germ cell cancer	0.0056	0.0174	CcSEcCtD
Loxapine—HTR1D—telencephalic ventricle—germ cell cancer	0.00554	0.00913	CbGeAlD
Loxapine—HTR2C—telencephalic ventricle—germ cell cancer	0.00549	0.00904	CbGeAlD
Loxapine—HTR7—cranial nerve—germ cell cancer	0.00543	0.00895	CbGeAlD
Loxapine—HTR7—pons—germ cell cancer	0.00536	0.00884	CbGeAlD
Loxapine—HTR2A—trigeminal nerve—germ cell cancer	0.00475	0.00783	CbGeAlD
Loxapine—Extrapyramidal disorder—Ifosfamide—germ cell cancer	0.00465	0.0145	CcSEcCtD
Loxapine—HTR1A—telencephalic ventricle—germ cell cancer	0.00462	0.00761	CbGeAlD
Loxapine—HTR2A—vagus nerve—germ cell cancer	0.00444	0.00732	CbGeAlD
Loxapine—HTR7—telencephalic ventricle—germ cell cancer	0.00441	0.00728	CbGeAlD
Loxapine—DRD1—ganglion—germ cell cancer	0.0044	0.00725	CbGeAlD
Loxapine—HTR3A—ganglion—germ cell cancer	0.00425	0.007	CbGeAlD
Loxapine—HTR5A—head—germ cell cancer	0.00424	0.00699	CbGeAlD
Loxapine—DRD2—telencephalic ventricle—germ cell cancer	0.00417	0.00688	CbGeAlD
Loxapine—Amenorrhoea—Ifosfamide—germ cell cancer	0.00398	0.0124	CcSEcCtD
Loxapine—Wheezing—Bleomycin—germ cell cancer	0.00398	0.0124	CcSEcCtD
Loxapine—Dyskinesia—Ifosfamide—germ cell cancer	0.00372	0.0116	CcSEcCtD
Loxapine—Dysarthria—Ifosfamide—germ cell cancer	0.0037	0.0115	CcSEcCtD
Loxapine—Cerebrovascular accident—Vinblastine—germ cell cancer	0.00359	0.0112	CcSEcCtD
Loxapine—Gait disturbance—Ifosfamide—germ cell cancer	0.00358	0.0112	CcSEcCtD
Loxapine—Liver injury—Cisplatin—germ cell cancer	0.00358	0.0112	CcSEcCtD
Loxapine—Muscle twitching—Ifosfamide—germ cell cancer	0.00356	0.0111	CcSEcCtD
Loxapine—HTR1B—ganglion—germ cell cancer	0.00356	0.00587	CbGeAlD
Loxapine—SLC6A3—ganglion—germ cell cancer	0.00353	0.00582	CbGeAlD
Loxapine—HRH4—bone marrow—germ cell cancer	0.00349	0.00576	CbGeAlD
Loxapine—HTR1D—ganglion—germ cell cancer	0.00345	0.00569	CbGeAlD
Loxapine—HTR2C—ganglion—germ cell cancer	0.00342	0.00563	CbGeAlD
Loxapine—Salivary hypersecretion—Ifosfamide—germ cell cancer	0.0034	0.0106	CcSEcCtD
Loxapine—HTR2A—cranial nerve—germ cell cancer	0.00338	0.00558	CbGeAlD
Loxapine—HTR2A—pons—germ cell cancer	0.00334	0.00551	CbGeAlD
Loxapine—Numbness—Etoposide—germ cell cancer	0.00333	0.0104	CcSEcCtD
Loxapine—HTR1E—brainstem—germ cell cancer	0.00327	0.0054	CbGeAlD
Loxapine—SLC6A4—ganglion—germ cell cancer	0.00324	0.00534	CbGeAlD
Loxapine—Sensory loss—Etoposide—germ cell cancer	0.00319	0.00994	CcSEcCtD
Loxapine—Dysarthria—Cisplatin—germ cell cancer	0.00319	0.00993	CcSEcCtD
Loxapine—Chest discomfort—Etoposide—germ cell cancer	0.00312	0.00973	CcSEcCtD
Loxapine—HTR5A—brain—germ cell cancer	0.00307	0.00506	CbGeAlD
Loxapine—Cerebrovascular accident—Bleomycin—germ cell cancer	0.00303	0.00945	CcSEcCtD
Loxapine—Hepatocellular injury—Cisplatin—germ cell cancer	0.00302	0.0094	CcSEcCtD
Loxapine—Wheezing—Cisplatin—germ cell cancer	0.00293	0.00913	CcSEcCtD
Loxapine—HTR1E—telencephalon—germ cell cancer	0.00291	0.00479	CbGeAlD
Loxapine—HTR1A—ganglion—germ cell cancer	0.00287	0.00474	CbGeAlD
Loxapine—SLC6A2—ganglion—germ cell cancer	0.00285	0.0047	CbGeAlD
Loxapine—HTR1B—blood vessel—germ cell cancer	0.00283	0.00467	CbGeAlD
Loxapine—HTR2A—telencephalic ventricle—germ cell cancer	0.00275	0.00454	CbGeAlD
Loxapine—HTR7—ganglion—germ cell cancer	0.00275	0.00453	CbGeAlD
Loxapine—HTR1D—blood vessel—germ cell cancer	0.00274	0.00452	CbGeAlD
Loxapine—DRD2—ganglion—germ cell cancer	0.0026	0.00428	CbGeAlD
Loxapine—Agranulocytosis—Vinblastine—germ cell cancer	0.00253	0.00788	CcSEcCtD
Loxapine—Bronchospasm—Bleomycin—germ cell cancer	0.00253	0.00787	CcSEcCtD
Loxapine—HTR2A—urine—germ cell cancer	0.00251	0.00414	CbGeAlD
Loxapine—Psychotic disorder—Ifosfamide—germ cell cancer	0.00248	0.00773	CcSEcCtD
Loxapine—HTR2A—appendage—germ cell cancer	0.00245	0.00403	CbGeAlD
Loxapine—Hypoaesthesia—Vinblastine—germ cell cancer	0.00242	0.00754	CcSEcCtD
Loxapine—Urinary retention—Ifosfamide—germ cell cancer	0.00241	0.00752	CcSEcCtD
Loxapine—Nasal congestion—Cisplatin—germ cell cancer	0.0024	0.00749	CcSEcCtD
Loxapine—Dysphagia—Dactinomycin—germ cell cancer	0.0024	0.00746	CcSEcCtD
Loxapine—HTR2A—pineal body—germ cell cancer	0.00239	0.00394	CbGeAlD
Loxapine—HTR7—endothelium—germ cell cancer	0.00237	0.0039	CbGeAlD
Loxapine—Weight decreased—Bleomycin—germ cell cancer	0.00232	0.00724	CcSEcCtD
Loxapine—HTR6—telencephalon—germ cell cancer	0.00228	0.00376	CbGeAlD
Loxapine—Cerebrovascular accident—Cisplatin—germ cell cancer	0.00223	0.00696	CcSEcCtD
Loxapine—DRD5—telencephalon—germ cell cancer	0.00222	0.00366	CbGeAlD
Loxapine—HTR7—blood vessel—germ cell cancer	0.00218	0.0036	CbGeAlD
Loxapine—CHRM5—eye—germ cell cancer	0.00218	0.0036	CbGeAlD
Loxapine—Bronchospasm—Ifosfamide—germ cell cancer	0.00216	0.00673	CcSEcCtD
Loxapine—Alopecia—Vinblastine—germ cell cancer	0.00215	0.0067	CcSEcCtD
Loxapine—HTR3A—trigeminal ganglion—germ cell cancer	0.00209	0.00344	CbGeAlD
Loxapine—Hypoaesthesia—Bleomycin—germ cell cancer	0.00205	0.00637	CcSEcCtD
Loxapine—DRD4—testis—germ cell cancer	0.00203	0.00334	CbGeAlD
Loxapine—Orthostatic hypotension—Cisplatin—germ cell cancer	0.002	0.00623	CcSEcCtD
Loxapine—Agranulocytosis—Dactinomycin—germ cell cancer	0.00199	0.00621	CcSEcCtD
Loxapine—HRH2—skin of body—germ cell cancer	0.00199	0.00328	CbGeAlD
Loxapine—HTR1E—female gonad—germ cell cancer	0.00197	0.00325	CbGeAlD
Loxapine—Renal failure—Ifosfamide—germ cell cancer	0.00192	0.00599	CcSEcCtD
Loxapine—Hepatitis—Dactinomycin—germ cell cancer	0.00192	0.00597	CcSEcCtD
Loxapine—DRD1—brainstem—germ cell cancer	0.00191	0.00315	CbGeAlD
Loxapine—CHRM5—skin of body—germ cell cancer	0.0019	0.00313	CbGeAlD
Loxapine—Leukopenia—Vinblastine—germ cell cancer	0.0019	0.00591	CcSEcCtD
Loxapine—HTR3A—brainstem—germ cell cancer	0.00185	0.00304	CbGeAlD
Loxapine—Convulsion—Vinblastine—germ cell cancer	0.00184	0.00572	CcSEcCtD
Loxapine—Hypertension—Vinblastine—germ cell cancer	0.00183	0.0057	CcSEcCtD
Loxapine—Agranulocytosis—Ifosfamide—germ cell cancer	0.00183	0.00569	CcSEcCtD
Loxapine—Alopecia—Bleomycin—germ cell cancer	0.00182	0.00566	CcSEcCtD
Loxapine—HTR1E—head—germ cell cancer	0.00181	0.00298	CbGeAlD
Loxapine—Hepatitis—Ifosfamide—germ cell cancer	0.00176	0.00547	CcSEcCtD
Loxapine—Dysarthria—Methotrexate—germ cell cancer	0.00175	0.00545	CcSEcCtD
Loxapine—HTR1B—trigeminal ganglion—germ cell cancer	0.00175	0.00288	CbGeAlD
Loxapine—Dysphagia—Etoposide—germ cell cancer	0.00173	0.0054	CcSEcCtD
Loxapine—HTR2A—ganglion—germ cell cancer	0.00171	0.00282	CbGeAlD
Loxapine—Bronchospasm—Etoposide—germ cell cancer	0.00171	0.00531	CcSEcCtD
Loxapine—DRD1—telencephalon—germ cell cancer	0.0017	0.0028	CbGeAlD
Loxapine—Alopecia—Dactinomycin—germ cell cancer	0.00169	0.00528	CcSEcCtD
Loxapine—HTR1D—trigeminal ganglion—germ cell cancer	0.00169	0.00279	CbGeAlD
Loxapine—Thrombocytopenia—Vinblastine—germ cell cancer	0.00169	0.00527	CcSEcCtD
Loxapine—Renal failure—Cisplatin—germ cell cancer	0.00166	0.00517	CcSEcCtD
Loxapine—HTR3A—telencephalon—germ cell cancer	0.00164	0.0027	CbGeAlD
Loxapine—Leukopenia—Bleomycin—germ cell cancer	0.0016	0.00499	CcSEcCtD
Loxapine—Angiopathy—Ifosfamide—germ cell cancer	0.00159	0.00497	CcSEcCtD
Loxapine—CHRM4—head—germ cell cancer	0.00159	0.00262	CbGeAlD
Loxapine—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00158	0.00493	CcSEcCtD
Loxapine—HTR7—neck—germ cell cancer	0.00156	0.00258	CbGeAlD
Loxapine—Cough—Bleomycin—germ cell cancer	0.00156	0.00487	CcSEcCtD
Loxapine—Paraesthesia—Vinblastine—germ cell cancer	0.00155	0.00484	CcSEcCtD
Loxapine—Alopecia—Ifosfamide—germ cell cancer	0.00155	0.00484	CcSEcCtD
Loxapine—HTR1B—brainstem—germ cell cancer	0.00155	0.00255	CbGeAlD
Loxapine—SLC6A3—brainstem—germ cell cancer	0.00154	0.00253	CbGeAlD
Loxapine—CHRM4—testis—germ cell cancer	0.00153	0.00253	CbGeAlD
Loxapine—Chest pain—Bleomycin—germ cell cancer	0.00152	0.00475	CcSEcCtD
Loxapine—DRD4—brain—germ cell cancer	0.00152	0.00251	CbGeAlD
Loxapine—Renal failure—Etoposide—germ cell cancer	0.00152	0.00473	CcSEcCtD
Loxapine—HRH2—adrenal gland—germ cell cancer	0.00152	0.0025	CbGeAlD
Loxapine—Jaundice—Etoposide—germ cell cancer	0.00151	0.00469	CcSEcCtD
Loxapine—DRD5—female gonad—germ cell cancer	0.00151	0.00248	CbGeAlD
Loxapine—HTR1D—brainstem—germ cell cancer	0.0015	0.00247	CbGeAlD
Loxapine—Leukopenia—Dactinomycin—germ cell cancer	0.00149	0.00465	CcSEcCtD
Loxapine—HTR2C—brainstem—germ cell cancer	0.00148	0.00245	CbGeAlD
Loxapine—Gynaecomastia—Methotrexate—germ cell cancer	0.00148	0.00461	CcSEcCtD
Loxapine—Constipation—Vinblastine—germ cell cancer	0.00148	0.00461	CcSEcCtD
Loxapine—HTR2A—endothelium—germ cell cancer	0.00148	0.00244	CbGeAlD
Loxapine—DRD3—head—germ cell cancer	0.00147	0.00243	CbGeAlD
Loxapine—Confusional state—Bleomycin—germ cell cancer	0.00147	0.00459	CcSEcCtD
Loxapine—Oedema—Bleomycin—germ cell cancer	0.00146	0.00455	CcSEcCtD
Loxapine—HTR1D—eye—germ cell cancer	0.00146	0.00241	CbGeAlD
Loxapine—Agranulocytosis—Etoposide—germ cell cancer	0.00144	0.00449	CcSEcCtD
Loxapine—Vision blurred—Ifosfamide—germ cell cancer	0.00144	0.00449	CcSEcCtD
Loxapine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00143	0.00446	CcSEcCtD
Loxapine—Feeling abnormal—Vinblastine—germ cell cancer	0.00143	0.00444	CcSEcCtD
Loxapine—HTR6—head—germ cell cancer	0.00142	0.00234	CbGeAlD
Loxapine—SLC6A4—brainstem—germ cell cancer	0.00141	0.00232	CbGeAlD
Loxapine—Agitation—Ifosfamide—germ cell cancer	0.00141	0.00438	CcSEcCtD
Loxapine—DRD5—endocrine gland—germ cell cancer	0.0014	0.00231	CbGeAlD
Loxapine—DRD5—head—germ cell cancer	0.00138	0.00228	CbGeAlD
Loxapine—Hypoaesthesia—Etoposide—germ cell cancer	0.00138	0.0043	CcSEcCtD
Loxapine—HTR1B—telencephalon—germ cell cancer	0.00137	0.00227	CbGeAlD
Loxapine—Leukopenia—Ifosfamide—germ cell cancer	0.00137	0.00427	CcSEcCtD
Loxapine—Photosensitivity—Methotrexate—germ cell cancer	0.00137	0.00426	CcSEcCtD
Loxapine—CHRM2—telencephalon—germ cell cancer	0.00137	0.00225	CbGeAlD
Loxapine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00137	0.00425	CcSEcCtD
Loxapine—Hypotension—Bleomycin—germ cell cancer	0.00136	0.00425	CcSEcCtD
Loxapine—SLC6A3—telencephalon—germ cell cancer	0.00136	0.00225	CbGeAlD
Loxapine—HTR2A—blood vessel—germ cell cancer	0.00136	0.00225	CbGeAlD
Loxapine—Oedema—Dactinomycin—germ cell cancer	0.00136	0.00424	CcSEcCtD
Loxapine—Alopecia—Cisplatin—germ cell cancer	0.00134	0.00417	CcSEcCtD
Loxapine—Cough—Ifosfamide—germ cell cancer	0.00133	0.00416	CcSEcCtD
Loxapine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00133	0.00415	CcSEcCtD
Loxapine—HTR1D—telencephalon—germ cell cancer	0.00133	0.00219	CbGeAlD
Loxapine—Convulsion—Ifosfamide—germ cell cancer	0.00133	0.00413	CcSEcCtD
Loxapine—Hypertension—Ifosfamide—germ cell cancer	0.00132	0.00411	CcSEcCtD
Loxapine—HTR2C—telencephalon—germ cell cancer	0.00132	0.00217	CbGeAlD
Loxapine—HRH2—endocrine gland—germ cell cancer	0.00131	0.00217	CbGeAlD
Loxapine—Paraesthesia—Bleomycin—germ cell cancer	0.00131	0.00409	CcSEcCtD
Loxapine—HTR1E—brain—germ cell cancer	0.00131	0.00216	CbGeAlD
Loxapine—Dyspnoea—Bleomycin—germ cell cancer	0.0013	0.00406	CcSEcCtD
Loxapine—Chest pain—Ifosfamide—germ cell cancer	0.0013	0.00406	CcSEcCtD
Loxapine—HRH2—head—germ cell cancer	0.0013	0.00214	CbGeAlD
Loxapine—ADRB1—telencephalon—germ cell cancer	0.00129	0.00213	CbGeAlD
Loxapine—Hypersensitivity—Vinblastine—germ cell cancer	0.00127	0.00397	CcSEcCtD
Loxapine—Muscle spasms—Cisplatin—germ cell cancer	0.00127	0.00395	CcSEcCtD
Loxapine—Angiopathy—Etoposide—germ cell cancer	0.00126	0.00392	CcSEcCtD
Loxapine—Confusional state—Ifosfamide—germ cell cancer	0.00126	0.00392	CcSEcCtD
Loxapine—Mediastinal disorder—Etoposide—germ cell cancer	0.00125	0.0039	CcSEcCtD
Loxapine—HTR1A—brainstem—germ cell cancer	0.00125	0.00206	CbGeAlD
Loxapine—SLC6A4—telencephalon—germ cell cancer	0.00125	0.00206	CbGeAlD
Loxapine—Oedema—Ifosfamide—germ cell cancer	0.00125	0.00389	CcSEcCtD
Loxapine—CHRM1—telencephalon—germ cell cancer	0.00124	0.00205	CbGeAlD
Loxapine—Vision blurred—Cisplatin—germ cell cancer	0.00124	0.00387	CcSEcCtD
Loxapine—Asthenia—Vinblastine—germ cell cancer	0.00124	0.00387	CcSEcCtD
Loxapine—ADRA2C—trigeminal ganglion—germ cell cancer	0.00124	0.00204	CbGeAlD
Loxapine—CHRM5—head—germ cell cancer	0.00124	0.00204	CbGeAlD
Loxapine—SLC6A2—brainstem—germ cell cancer	0.00124	0.00204	CbGeAlD
Loxapine—Tremor—Cisplatin—germ cell cancer	0.00124	0.00385	CcSEcCtD
Loxapine—Alopecia—Etoposide—germ cell cancer	0.00123	0.00382	CcSEcCtD
Loxapine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00123	0.00382	CcSEcCtD
Loxapine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00122	0.00381	CcSEcCtD
Loxapine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00122	0.00381	CcSEcCtD
Loxapine—DRD1—midbrain—germ cell cancer	0.00122	0.00201	CbGeAlD
Loxapine—Feeling abnormal—Bleomycin—germ cell cancer	0.0012	0.00375	CcSEcCtD
Loxapine—HTR7—brainstem—germ cell cancer	0.00119	0.00197	CbGeAlD
Loxapine—Dysgeusia—Etoposide—germ cell cancer	0.00118	0.00369	CcSEcCtD
Loxapine—Leukopenia—Cisplatin—germ cell cancer	0.00118	0.00368	CcSEcCtD
Loxapine—Fatigue—Dactinomycin—germ cell cancer	0.00117	0.00366	CcSEcCtD
Loxapine—Hypotension—Ifosfamide—germ cell cancer	0.00117	0.00363	CcSEcCtD
Loxapine—Muscle spasms—Etoposide—germ cell cancer	0.00116	0.00362	CcSEcCtD
Loxapine—ADRA1A—brainstem—germ cell cancer	0.00115	0.0019	CbGeAlD
Loxapine—CHRM4—brain—germ cell cancer	0.00115	0.0019	CbGeAlD
Loxapine—Dizziness—Vinblastine—germ cell cancer	0.00114	0.00356	CcSEcCtD
Loxapine—Convulsion—Cisplatin—germ cell cancer	0.00114	0.00356	CcSEcCtD
Loxapine—ADRA1B—head—germ cell cancer	0.00113	0.00187	CbGeAlD
Loxapine—DRD2—brainstem—germ cell cancer	0.00113	0.00186	CbGeAlD
Loxapine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00112	0.0035	CcSEcCtD
Loxapine—Paraesthesia—Ifosfamide—germ cell cancer	0.00112	0.00349	CcSEcCtD
Loxapine—CHRM3—telencephalon—germ cell cancer	0.00111	0.00184	CbGeAlD
Loxapine—Dyspnoea—Ifosfamide—germ cell cancer	0.00111	0.00347	CcSEcCtD
Loxapine—Somnolence—Ifosfamide—germ cell cancer	0.00111	0.00346	CcSEcCtD
Loxapine—HTR1A—telencephalon—germ cell cancer	0.00111	0.00183	CbGeAlD
Loxapine—Vomiting—Vinblastine—germ cell cancer	0.0011	0.00343	CcSEcCtD
Loxapine—SLC6A2—telencephalon—germ cell cancer	0.0011	0.00181	CbGeAlD
Loxapine—DRD2—eye—germ cell cancer	0.0011	0.00181	CbGeAlD
Loxapine—DRD2—retina—germ cell cancer	0.00109	0.0018	CbGeAlD
Loxapine—Headache—Vinblastine—germ cell cancer	0.00108	0.00337	CcSEcCtD
Loxapine—Leukopenia—Etoposide—germ cell cancer	0.00108	0.00337	CcSEcCtD
Loxapine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00108	0.00336	CcSEcCtD
Loxapine—Fatigue—Ifosfamide—germ cell cancer	0.00108	0.00335	CcSEcCtD
Loxapine—Oedema—Cisplatin—germ cell cancer	0.00108	0.00335	CcSEcCtD
Loxapine—Hypersensitivity—Bleomycin—germ cell cancer	0.00108	0.00335	CcSEcCtD
Loxapine—DRD3—brain—germ cell cancer	0.00107	0.00176	CbGeAlD
Loxapine—Constipation—Ifosfamide—germ cell cancer	0.00107	0.00333	CcSEcCtD
Loxapine—Loss of consciousness—Etoposide—germ cell cancer	0.00106	0.00331	CcSEcCtD
Loxapine—HTR7—telencephalon—germ cell cancer	0.00106	0.00175	CbGeAlD
Loxapine—DRD1—head—germ cell cancer	0.00106	0.00174	CbGeAlD
Loxapine—Nervous system disorder—Cisplatin—germ cell cancer	0.00106	0.00329	CcSEcCtD
Loxapine—Cough—Etoposide—germ cell cancer	0.00105	0.00328	CcSEcCtD
Loxapine—Thrombocytopenia—Cisplatin—germ cell cancer	0.00105	0.00328	CcSEcCtD
Loxapine—Tachycardia—Cisplatin—germ cell cancer	0.00105	0.00327	CcSEcCtD
Loxapine—Asthenia—Bleomycin—germ cell cancer	0.00105	0.00326	CcSEcCtD
Loxapine—Convulsion—Etoposide—germ cell cancer	0.00105	0.00326	CcSEcCtD
Loxapine—Hypertension—Etoposide—germ cell cancer	0.00104	0.00325	CcSEcCtD
Loxapine—SLC6A2—decidua—germ cell cancer	0.00104	0.00172	CbGeAlD
Loxapine—HTR2C—medulla oblongata—germ cell cancer	0.00104	0.00171	CbGeAlD
Loxapine—Pruritus—Bleomycin—germ cell cancer	0.00103	0.00322	CcSEcCtD
Loxapine—HTR6—brain—germ cell cancer	0.00103	0.0017	CbGeAlD
Loxapine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00103	0.0032	CcSEcCtD
Loxapine—Chest pain—Etoposide—germ cell cancer	0.00103	0.0032	CcSEcCtD
Loxapine—Nausea—Vinblastine—germ cell cancer	0.00103	0.0032	CcSEcCtD
Loxapine—ADRA1A—telencephalon—germ cell cancer	0.00102	0.00169	CbGeAlD
Loxapine—HTR3A—head—germ cell cancer	0.00102	0.00168	CbGeAlD
Loxapine—HRH1—trigeminal ganglion—germ cell cancer	0.00101	0.00166	CbGeAlD
Loxapine—Hypotension—Cisplatin—germ cell cancer	0.00101	0.00313	CcSEcCtD
Loxapine—Hypersensitivity—Dactinomycin—germ cell cancer	0.001	0.00313	CcSEcCtD
Loxapine—DRD2—telencephalon—germ cell cancer	0.001	0.00165	CbGeAlD
Loxapine—DRD5—brain—germ cell cancer	0.001	0.00165	CbGeAlD
Loxapine—Confusional state—Etoposide—germ cell cancer	0.000994	0.0031	CcSEcCtD
Loxapine—ADRA2A—trigeminal ganglion—germ cell cancer	0.00099	0.00163	CbGeAlD
Loxapine—HTR1B—midbrain—germ cell cancer	0.000987	0.00163	CbGeAlD
Loxapine—SLC6A3—midbrain—germ cell cancer	0.000979	0.00161	CbGeAlD
Loxapine—Asthenia—Dactinomycin—germ cell cancer	0.000977	0.00304	CcSEcCtD
Loxapine—HTR2A—neck—germ cell cancer	0.000974	0.00161	CbGeAlD
Loxapine—ADRA2C—telencephalon—germ cell cancer	0.000974	0.00161	CbGeAlD
Loxapine—Paraesthesia—Cisplatin—germ cell cancer	0.000966	0.00301	CcSEcCtD
Loxapine—Thrombocytopenia—Etoposide—germ cell cancer	0.000965	0.00301	CcSEcCtD
Loxapine—HTR1B—spinal cord—germ cell cancer	0.000963	0.00159	CbGeAlD
Loxapine—Tachycardia—Etoposide—germ cell cancer	0.000962	0.003	CcSEcCtD
Loxapine—Dyspnoea—Cisplatin—germ cell cancer	0.000959	0.00299	CcSEcCtD
Loxapine—HTR1D—midbrain—germ cell cancer	0.000955	0.00157	CbGeAlD
Loxapine—SLC6A3—spinal cord—germ cell cancer	0.000955	0.00157	CbGeAlD
Loxapine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000948	0.00295	CcSEcCtD
Loxapine—HTR2C—midbrain—germ cell cancer	0.000946	0.00156	CbGeAlD
Loxapine—HRH2—brain—germ cell cancer	0.000941	0.00155	CbGeAlD
Loxapine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000929	0.00289	CcSEcCtD
Loxapine—Vomiting—Bleomycin—germ cell cancer	0.000929	0.00289	CcSEcCtD
Loxapine—Drowsiness—Methotrexate—germ cell cancer	0.000926	0.00288	CcSEcCtD
Loxapine—ADRA2C—decidua—germ cell cancer	0.000923	0.00152	CbGeAlD
Loxapine—HTR2C—spinal cord—germ cell cancer	0.000923	0.00152	CbGeAlD
Loxapine—Hypotension—Etoposide—germ cell cancer	0.000921	0.00287	CcSEcCtD
Loxapine—Rash—Bleomycin—germ cell cancer	0.000921	0.00287	CcSEcCtD
Loxapine—Dermatitis—Bleomycin—germ cell cancer	0.00092	0.00287	CcSEcCtD
Loxapine—Hypersensitivity—Ifosfamide—germ cell cancer	0.00092	0.00287	CcSEcCtD
Loxapine—SLC6A2—gonad—germ cell cancer	0.000918	0.00151	CbGeAlD
Loxapine—Renal failure—Methotrexate—germ cell cancer	0.00091	0.00284	CcSEcCtD
Loxapine—HRH2—lymph node—germ cell cancer	0.000909	0.0015	CbGeAlD
Loxapine—CHRM5—brain—germ cell cancer	0.000899	0.00148	CbGeAlD
Loxapine—SLC6A4—midbrain—germ cell cancer	0.000897	0.00148	CbGeAlD
Loxapine—Asthenia—Ifosfamide—germ cell cancer	0.000896	0.00279	CcSEcCtD
Loxapine—Feeling abnormal—Cisplatin—germ cell cancer	0.000887	0.00276	CcSEcCtD
Loxapine—Paraesthesia—Etoposide—germ cell cancer	0.000885	0.00276	CcSEcCtD
Loxapine—HTR7—gonad—germ cell cancer	0.000884	0.00146	CbGeAlD
Loxapine—Pruritus—Ifosfamide—germ cell cancer	0.000883	0.00275	CcSEcCtD
Loxapine—Dyspnoea—Etoposide—germ cell cancer	0.000879	0.00274	CcSEcCtD
Loxapine—Somnolence—Etoposide—germ cell cancer	0.000876	0.00273	CcSEcCtD
Loxapine—SLC6A4—spinal cord—germ cell cancer	0.000875	0.00144	CbGeAlD
Loxapine—HRH1—eye—germ cell cancer	0.000868	0.00143	CbGeAlD
Loxapine—Nausea—Bleomycin—germ cell cancer	0.000868	0.0027	CcSEcCtD
Loxapine—HTR1B—endocrine gland—germ cell cancer	0.000867	0.00143	CbGeAlD
Loxapine—Vomiting—Dactinomycin—germ cell cancer	0.000866	0.0027	CcSEcCtD
Loxapine—Agranulocytosis—Methotrexate—germ cell cancer	0.000864	0.00269	CcSEcCtD
Loxapine—SLC6A2—medulla oblongata—germ cell cancer	0.000864	0.00142	CbGeAlD
Loxapine—CHRM2—endocrine gland—germ cell cancer	0.000862	0.00142	CbGeAlD
Loxapine—Rash—Dactinomycin—germ cell cancer	0.000859	0.00268	CcSEcCtD
Loxapine—HTR1B—head—germ cell cancer	0.000856	0.00141	CbGeAlD
Loxapine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000851	0.00265	CcSEcCtD
Loxapine—CHRM2—head—germ cell cancer	0.000851	0.0014	CbGeAlD
Loxapine—Fatigue—Etoposide—germ cell cancer	0.00085	0.00265	CcSEcCtD
Loxapine—SLC6A3—head—germ cell cancer	0.000849	0.0014	CbGeAlD
Loxapine—Constipation—Etoposide—germ cell cancer	0.000843	0.00263	CcSEcCtD
Loxapine—HTR7—medulla oblongata—germ cell cancer	0.000833	0.00137	CbGeAlD
Loxapine—Hepatitis—Methotrexate—germ cell cancer	0.000831	0.00259	CcSEcCtD
Loxapine—HTR1D—head—germ cell cancer	0.000828	0.00137	CbGeAlD
Loxapine—Dizziness—Ifosfamide—germ cell cancer	0.000825	0.00257	CcSEcCtD
Loxapine—ADRA1B—brain—germ cell cancer	0.000821	0.00135	CbGeAlD
Loxapine—HTR2C—head—germ cell cancer	0.00082	0.00135	CbGeAlD
Loxapine—SLC6A3—testis—germ cell cancer	0.00082	0.00135	CbGeAlD
Loxapine—DRD2—pituitary gland—germ cell cancer	0.000816	0.00134	CbGeAlD
Loxapine—ADRB1—endocrine gland—germ cell cancer	0.000815	0.00134	CbGeAlD
Loxapine—HTR2A—embryo—germ cell cancer	0.000813	0.00134	CbGeAlD
Loxapine—Feeling abnormal—Etoposide—germ cell cancer	0.000812	0.00253	CcSEcCtD
Loxapine—Nausea—Dactinomycin—germ cell cancer	0.000809	0.00252	CcSEcCtD
Loxapine—ADRA2C—uterus—germ cell cancer	0.000808	0.00133	CbGeAlD
Loxapine—HTR1A—adrenal gland—germ cell cancer	0.000807	0.00133	CbGeAlD
Loxapine—ADRB1—head—germ cell cancer	0.000805	0.00133	CbGeAlD
Loxapine—SLC6A2—adrenal gland—germ cell cancer	0.0008	0.00132	CbGeAlD
Loxapine—HTR1A—midbrain—germ cell cancer	0.000796	0.00131	CbGeAlD
Loxapine—Vomiting—Ifosfamide—germ cell cancer	0.000794	0.00247	CcSEcCtD
Loxapine—ADRA2C—pituitary gland—germ cell cancer	0.000793	0.00131	CbGeAlD
Loxapine—Hypersensitivity—Cisplatin—germ cell cancer	0.000793	0.00247	CcSEcCtD
Loxapine—HRH1—telencephalon—germ cell cancer	0.000791	0.0013	CbGeAlD
Loxapine—SLC6A4—endocrine gland—germ cell cancer	0.000788	0.0013	CbGeAlD
Loxapine—Rash—Ifosfamide—germ cell cancer	0.000787	0.00245	CcSEcCtD
Loxapine—Dermatitis—Ifosfamide—germ cell cancer	0.000786	0.00245	CcSEcCtD
Loxapine—CHRM1—endocrine gland—germ cell cancer	0.000785	0.00129	CbGeAlD
Loxapine—SLC6A4—head—germ cell cancer	0.000778	0.00128	CbGeAlD
Loxapine—ADRA2A—telencephalon—germ cell cancer	0.000777	0.00128	CbGeAlD
Loxapine—HTR1A—spinal cord—germ cell cancer	0.000777	0.00128	CbGeAlD
Loxapine—CHRM1—head—germ cell cancer	0.000775	0.00128	CbGeAlD
Loxapine—Asthenia—Cisplatin—germ cell cancer	0.000772	0.00241	CcSEcCtD
Loxapine—HTR7—adrenal gland—germ cell cancer	0.000771	0.00127	CbGeAlD
Loxapine—ADRA2C—medulla oblongata—germ cell cancer	0.000765	0.00126	CbGeAlD
Loxapine—DRD1—brain—germ cell cancer	0.000765	0.00126	CbGeAlD
Loxapine—HTR7—midbrain—germ cell cancer	0.000761	0.00125	CbGeAlD
Loxapine—SLC6A3—cerebellum—germ cell cancer	0.000757	0.00125	CbGeAlD
Loxapine—CHRM3—female gonad—germ cell cancer	0.000755	0.00124	CbGeAlD
Loxapine—Angiopathy—Methotrexate—germ cell cancer	0.000754	0.00235	CcSEcCtD
Loxapine—HRH1—decidua—germ cell cancer	0.00075	0.00124	CbGeAlD
Loxapine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000749	0.00233	CcSEcCtD
Loxapine—HTR2A—brainstem—germ cell cancer	0.000745	0.00123	CbGeAlD
Loxapine—ADRA1A—adrenal gland—germ cell cancer	0.000744	0.00123	CbGeAlD
Loxapine—HTR7—spinal cord—germ cell cancer	0.000742	0.00122	CbGeAlD
Loxapine—Nausea—Ifosfamide—germ cell cancer	0.000741	0.00231	CcSEcCtD
Loxapine—HTR3A—brain—germ cell cancer	0.000739	0.00122	CbGeAlD
Loxapine—ADRA2A—decidua—germ cell cancer	0.000737	0.00121	CbGeAlD
Loxapine—Alopecia—Methotrexate—germ cell cancer	0.000734	0.00229	CcSEcCtD
Loxapine—Hypersensitivity—Etoposide—germ cell cancer	0.000726	0.00226	CcSEcCtD
Loxapine—HTR2A—eye—germ cell cancer	0.000725	0.0012	CbGeAlD
Loxapine—DRD2—midbrain—germ cell cancer	0.00072	0.00119	CbGeAlD
Loxapine—HTR2A—retina—germ cell cancer	0.000718	0.00118	CbGeAlD
Loxapine—Dysgeusia—Methotrexate—germ cell cancer	0.000709	0.00221	CcSEcCtD
Loxapine—ADRA2C—adrenal gland—germ cell cancer	0.000708	0.00117	CbGeAlD
Loxapine—Asthenia—Etoposide—germ cell cancer	0.000707	0.0022	CcSEcCtD
Loxapine—CHRM3—endocrine gland—germ cell cancer	0.000702	0.00116	CbGeAlD
Loxapine—ADRA2C—midbrain—germ cell cancer	0.000699	0.00115	CbGeAlD
Loxapine—HTR1A—endocrine gland—germ cell cancer	0.000699	0.00115	CbGeAlD
Loxapine—Pruritus—Etoposide—germ cell cancer	0.000697	0.00217	CcSEcCtD
Loxapine—SLC6A2—endocrine gland—germ cell cancer	0.000694	0.00114	CbGeAlD
Loxapine—CHRM3—head—germ cell cancer	0.000693	0.00114	CbGeAlD
Loxapine—HTR1A—head—germ cell cancer	0.00069	0.00114	CbGeAlD
Loxapine—SLC6A2—head—germ cell cancer	0.000685	0.00113	CbGeAlD
Loxapine—Vomiting—Cisplatin—germ cell cancer	0.000684	0.00213	CcSEcCtD
Loxapine—ADRA2C—spinal cord—germ cell cancer	0.000682	0.00113	CbGeAlD
Loxapine—Vision blurred—Methotrexate—germ cell cancer	0.000682	0.00212	CcSEcCtD
Loxapine—Rash—Cisplatin—germ cell cancer	0.000679	0.00211	CcSEcCtD
Loxapine—Dermatitis—Cisplatin—germ cell cancer	0.000678	0.00211	CcSEcCtD
Loxapine—CHRM3—testis—germ cell cancer	0.00067	0.0011	CbGeAlD
Loxapine—HTR7—endocrine gland—germ cell cancer	0.000668	0.0011	CbGeAlD
Loxapine—SLC6A2—testis—germ cell cancer	0.000661	0.00109	CbGeAlD
Loxapine—HTR2A—telencephalon—germ cell cancer	0.000661	0.00109	CbGeAlD
Loxapine—ADRA2C—female gonad—germ cell cancer	0.000661	0.00109	CbGeAlD
Loxapine—HTR7—head—germ cell cancer	0.00066	0.00109	CbGeAlD
Loxapine—Dizziness—Etoposide—germ cell cancer	0.000652	0.00203	CcSEcCtD
Loxapine—ADRA2A—gonad—germ cell cancer	0.000649	0.00107	CbGeAlD
Loxapine—Leukopenia—Methotrexate—germ cell cancer	0.000648	0.00202	CcSEcCtD
Loxapine—ADRA1A—endocrine gland—germ cell cancer	0.000645	0.00106	CbGeAlD
Loxapine—ADRA2A—uterus—germ cell cancer	0.000644	0.00106	CbGeAlD
Loxapine—Nausea—Cisplatin—germ cell cancer	0.000639	0.00199	CcSEcCtD
Loxapine—HTR7—testis—germ cell cancer	0.000637	0.00105	CbGeAlD
Loxapine—ADRA1A—head—germ cell cancer	0.000637	0.00105	CbGeAlD
Loxapine—ADRA2A—pituitary gland—germ cell cancer	0.000633	0.00104	CbGeAlD
Loxapine—DRD2—endocrine gland—germ cell cancer	0.000632	0.00104	CbGeAlD
Loxapine—Cough—Methotrexate—germ cell cancer	0.000631	0.00197	CcSEcCtD
Loxapine—Convulsion—Methotrexate—germ cell cancer	0.000627	0.00195	CcSEcCtD
Loxapine—Vomiting—Etoposide—germ cell cancer	0.000627	0.00195	CcSEcCtD
Loxapine—DRD2—head—germ cell cancer	0.000624	0.00103	CbGeAlD
Loxapine—Rash—Etoposide—germ cell cancer	0.000622	0.00194	CcSEcCtD
Loxapine—Dermatitis—Etoposide—germ cell cancer	0.000621	0.00193	CcSEcCtD
Loxapine—HTR1B—brain—germ cell cancer	0.00062	0.00102	CbGeAlD
Loxapine—Headache—Etoposide—germ cell cancer	0.000618	0.00192	CcSEcCtD
Loxapine—CHRM2—brain—germ cell cancer	0.000617	0.00102	CbGeAlD
Loxapine—HTR1A—cerebellum—germ cell cancer	0.000616	0.00102	CbGeAlD
Loxapine—Chest pain—Methotrexate—germ cell cancer	0.000616	0.00192	CcSEcCtD
Loxapine—SLC6A3—brain—germ cell cancer	0.000615	0.00101	CbGeAlD
Loxapine—ADRA2A—medulla oblongata—germ cell cancer	0.000611	0.00101	CbGeAlD
Loxapine—ADRA2C—head—germ cell cancer	0.000607	0.001	CbGeAlD
Loxapine—DRD2—testis—germ cell cancer	0.000603	0.000994	CbGeAlD
Loxapine—HTR1D—brain—germ cell cancer	0.0006	0.00099	CbGeAlD
Loxapine—Confusional state—Methotrexate—germ cell cancer	0.000595	0.00185	CcSEcCtD
Loxapine—HTR2C—brain—germ cell cancer	0.000594	0.00098	CbGeAlD
Loxapine—HTR7—cerebellum—germ cell cancer	0.000589	0.000971	CbGeAlD
Loxapine—ADRA2C—testis—germ cell cancer	0.000586	0.000966	CbGeAlD
Loxapine—Nausea—Etoposide—germ cell cancer	0.000586	0.00182	CcSEcCtD
Loxapine—ADRB1—brain—germ cell cancer	0.000583	0.000962	CbGeAlD
Loxapine—Nervous system disorder—Methotrexate—germ cell cancer	0.000579	0.0018	CcSEcCtD
Loxapine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000578	0.0018	CcSEcCtD
Loxapine—HRH1—adrenal gland—germ cell cancer	0.000576	0.000949	CbGeAlD
Loxapine—ADRA1A—cerebellum—germ cell cancer	0.000568	0.000936	CbGeAlD
Loxapine—ADRA2A—adrenal gland—germ cell cancer	0.000565	0.000932	CbGeAlD
Loxapine—SLC6A4—brain—germ cell cancer	0.000564	0.000929	CbGeAlD
Loxapine—CHRM1—brain—germ cell cancer	0.000561	0.000925	CbGeAlD
Loxapine—ADRA2A—midbrain—germ cell cancer	0.000558	0.00092	CbGeAlD
Loxapine—DRD2—cerebellum—germ cell cancer	0.000557	0.000918	CbGeAlD
Loxapine—Hypotension—Methotrexate—germ cell cancer	0.000552	0.00172	CcSEcCtD
Loxapine—HTR2A—gonad—germ cell cancer	0.000552	0.000909	CbGeAlD
Loxapine—ADRA2A—spinal cord—germ cell cancer	0.000545	0.000898	CbGeAlD
Loxapine—ADRA2C—cerebellum—germ cell cancer	0.000541	0.000892	CbGeAlD
Loxapine—HTR2A—pituitary gland—germ cell cancer	0.000538	0.000887	CbGeAlD
Loxapine—HRH1—female gonad—germ cell cancer	0.000537	0.000885	CbGeAlD
Loxapine—Insomnia—Methotrexate—germ cell cancer	0.000534	0.00166	CcSEcCtD
Loxapine—Paraesthesia—Methotrexate—germ cell cancer	0.00053	0.00165	CcSEcCtD
Loxapine—ADRA2A—female gonad—germ cell cancer	0.000527	0.000869	CbGeAlD
Loxapine—Dyspnoea—Methotrexate—germ cell cancer	0.000526	0.00164	CcSEcCtD
Loxapine—Somnolence—Methotrexate—germ cell cancer	0.000525	0.00164	CcSEcCtD
Loxapine—HTR2A—medulla oblongata—germ cell cancer	0.000519	0.000856	CbGeAlD
Loxapine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00051	0.00159	CcSEcCtD
Loxapine—Fatigue—Methotrexate—germ cell cancer	0.000509	0.00159	CcSEcCtD
Loxapine—CHRM3—brain—germ cell cancer	0.000502	0.000828	CbGeAlD
Loxapine—HTR1A—brain—germ cell cancer	0.0005	0.000825	CbGeAlD
Loxapine—HRH1—endocrine gland—germ cell cancer	0.000499	0.000823	CbGeAlD
Loxapine—SLC6A2—brain—germ cell cancer	0.000496	0.000818	CbGeAlD
Loxapine—HRH1—head—germ cell cancer	0.000493	0.000812	CbGeAlD
Loxapine—ADRA2A—endocrine gland—germ cell cancer	0.00049	0.000808	CbGeAlD
Loxapine—Feeling abnormal—Methotrexate—germ cell cancer	0.000487	0.00152	CcSEcCtD
Loxapine—ADRA2A—head—germ cell cancer	0.000484	0.000798	CbGeAlD
Loxapine—HTR2A—adrenal gland—germ cell cancer	0.000481	0.000792	CbGeAlD
Loxapine—SLC6A2—lymph node—germ cell cancer	0.000479	0.00079	CbGeAlD
Loxapine—HTR7—brain—germ cell cancer	0.000478	0.000788	CbGeAlD
Loxapine—HRH1—testis—germ cell cancer	0.000476	0.000785	CbGeAlD
Loxapine—HTR2A—midbrain—germ cell cancer	0.000475	0.000782	CbGeAlD
Loxapine—ADRA2A—testis—germ cell cancer	0.000468	0.000771	CbGeAlD
Loxapine—HTR2A—spinal cord—germ cell cancer	0.000463	0.000763	CbGeAlD
Loxapine—ADRA1A—brain—germ cell cancer	0.000461	0.00076	CbGeAlD
Loxapine—DRD2—brain—germ cell cancer	0.000452	0.000745	CbGeAlD
Loxapine—ADRA2C—brain—germ cell cancer	0.00044	0.000725	CbGeAlD
Loxapine—Hypersensitivity—Methotrexate—germ cell cancer	0.000435	0.00136	CcSEcCtD
Loxapine—ADRA2A—cerebellum—germ cell cancer	0.000432	0.000712	CbGeAlD
Loxapine—ADRA2C—lymph node—germ cell cancer	0.000425	0.0007	CbGeAlD
Loxapine—Asthenia—Methotrexate—germ cell cancer	0.000424	0.00132	CcSEcCtD
Loxapine—Pruritus—Methotrexate—germ cell cancer	0.000418	0.0013	CcSEcCtD
Loxapine—HTR2A—endocrine gland—germ cell cancer	0.000417	0.000687	CbGeAlD
Loxapine—HTR2A—head—germ cell cancer	0.000412	0.000678	CbGeAlD
Loxapine—HTR2A—testis—germ cell cancer	0.000398	0.000655	CbGeAlD
Loxapine—Dizziness—Methotrexate—germ cell cancer	0.00039	0.00122	CcSEcCtD
Loxapine—Vomiting—Methotrexate—germ cell cancer	0.000375	0.00117	CcSEcCtD
Loxapine—Rash—Methotrexate—germ cell cancer	0.000372	0.00116	CcSEcCtD
Loxapine—Dermatitis—Methotrexate—germ cell cancer	0.000372	0.00116	CcSEcCtD
Loxapine—Headache—Methotrexate—germ cell cancer	0.00037	0.00115	CcSEcCtD
Loxapine—HTR2A—cerebellum—germ cell cancer	0.000367	0.000605	CbGeAlD
Loxapine—HRH1—brain—germ cell cancer	0.000357	0.000589	CbGeAlD
Loxapine—Nausea—Methotrexate—germ cell cancer	0.000351	0.00109	CcSEcCtD
Loxapine—ADRA2A—brain—germ cell cancer	0.000351	0.000578	CbGeAlD
Loxapine—HRH1—lymph node—germ cell cancer	0.000345	0.000569	CbGeAlD
Loxapine—ADRA2A—lymph node—germ cell cancer	0.000339	0.000559	CbGeAlD
Loxapine—HTR2A—brain—germ cell cancer	0.000298	0.000492	CbGeAlD
Loxapine—HTR1D—Signaling Pathways—KITLG—germ cell cancer	3.3e-05	0.000456	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—H2AFZ—germ cell cancer	3.26e-05	0.000451	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—AVP—germ cell cancer	3.25e-05	0.000449	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—AVP—germ cell cancer	3.25e-05	0.000448	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—KITLG—germ cell cancer	3.23e-05	0.000446	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—AVP—germ cell cancer	3.22e-05	0.000445	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—FGFR3—germ cell cancer	3.22e-05	0.000445	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—FGFR3—germ cell cancer	3.2e-05	0.000442	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—AVP—germ cell cancer	3.2e-05	0.000442	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—KITLG—germ cell cancer	3.18e-05	0.000439	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—AVP—germ cell cancer	3.16e-05	0.000436	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—KITLG—germ cell cancer	3.14e-05	0.000433	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—FGF4—germ cell cancer	3.13e-05	0.000432	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—H2AFZ—germ cell cancer	3.11e-05	0.00043	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—AVP—germ cell cancer	3.11e-05	0.000429	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—FGF4—germ cell cancer	3.1e-05	0.000428	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—OXT—germ cell cancer	3.08e-05	0.000425	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—H2AFZ—germ cell cancer	3.07e-05	0.000424	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—AVP—germ cell cancer	3.07e-05	0.000423	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—OXT—germ cell cancer	3.03e-05	0.000419	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—OXT—germ cell cancer	3.03e-05	0.000418	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—OXT—germ cell cancer	3.02e-05	0.000416	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—OXT—germ cell cancer	3.01e-05	0.000415	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—KITLG—germ cell cancer	3e-05	0.000415	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—FGF4—germ cell cancer	3e-05	0.000414	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—FGF4—germ cell cancer	2.98e-05	0.000412	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—OXT—germ cell cancer	2.98e-05	0.000411	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—OXT—germ cell cancer	2.97e-05	0.00041	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—KIT—germ cell cancer	2.96e-05	0.000408	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—KIT—germ cell cancer	2.94e-05	0.000406	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—AVP—germ cell cancer	2.94e-05	0.000405	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—FGF4—germ cell cancer	2.9e-05	0.0004	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—KITLG—germ cell cancer	2.86e-05	0.000395	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—FGF4—germ cell cancer	2.85e-05	0.000394	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—KITLG—germ cell cancer	2.82e-05	0.00039	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—AVP—germ cell cancer	2.8e-05	0.000386	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—H2AFZ—germ cell cancer	2.8e-05	0.000386	CbGpPWpGaD
Loxapine—HRH4—Signaling by GPCR—HRAS—germ cell cancer	2.79e-05	0.000385	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—TP53—germ cell cancer	2.78e-05	0.000384	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—H2AFZ—germ cell cancer	2.77e-05	0.000383	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—AVP—germ cell cancer	2.76e-05	0.000381	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—OXT—germ cell cancer	2.76e-05	0.000381	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—H2AFZ—germ cell cancer	2.67e-05	0.000369	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—H2AFZ—germ cell cancer	2.66e-05	0.000367	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—HRAS—germ cell cancer	2.66e-05	0.000367	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—FGF4—germ cell cancer	2.63e-05	0.000363	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—H2AFZ—germ cell cancer	2.59e-05	0.000357	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—FGF4—germ cell cancer	2.59e-05	0.000357	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—FGF4—germ cell cancer	2.58e-05	0.000357	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—FGF4—germ cell cancer	2.57e-05	0.000355	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—KITLG—germ cell cancer	2.57e-05	0.000355	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—FGF4—germ cell cancer	2.57e-05	0.000354	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—KITLG—germ cell cancer	2.55e-05	0.000352	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—H2AFZ—germ cell cancer	2.55e-05	0.000352	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—FGF4—germ cell cancer	2.54e-05	0.000351	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—FGF4—germ cell cancer	2.53e-05	0.00035	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—AVP—germ cell cancer	2.51e-05	0.000347	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—AVP—germ cell cancer	2.49e-05	0.000344	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—FGFR3—germ cell cancer	2.47e-05	0.000341	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—FGFR3—germ cell cancer	2.47e-05	0.000341	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—KITLG—germ cell cancer	2.46e-05	0.00034	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—FGFR3—germ cell cancer	2.45e-05	0.000339	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—KITLG—germ cell cancer	2.45e-05	0.000338	CbGpPWpGaD
Loxapine—HTR1E—Signaling by GPCR—HRAS—germ cell cancer	2.43e-05	0.000335	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—AVP—germ cell cancer	2.41e-05	0.000332	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—FGFR3—germ cell cancer	2.4e-05	0.000332	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—AVP—germ cell cancer	2.39e-05	0.00033	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—KITLG—germ cell cancer	2.38e-05	0.000329	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—FGFR3—germ cell cancer	2.36e-05	0.000326	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—FGF4—germ cell cancer	2.35e-05	0.000325	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—H2AFZ—germ cell cancer	2.35e-05	0.000324	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—KITLG—germ cell cancer	2.34e-05	0.000324	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—FGFR3—germ cell cancer	2.33e-05	0.000322	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—AVP—germ cell cancer	2.33e-05	0.000321	CbGpPWpGaD
Loxapine—ADRA2B—Hemostasis—TP53—germ cell cancer	2.32e-05	0.00032	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—H2AFZ—germ cell cancer	2.31e-05	0.000319	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—H2AFZ—germ cell cancer	2.31e-05	0.000318	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—H2AFZ—germ cell cancer	2.3e-05	0.000317	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—H2AFZ—germ cell cancer	2.29e-05	0.000316	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—AVP—germ cell cancer	2.29e-05	0.000316	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—H2AFZ—germ cell cancer	2.27e-05	0.000313	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—KIT—germ cell cancer	2.27e-05	0.000313	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—KIT—germ cell cancer	2.27e-05	0.000313	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—H2AFZ—germ cell cancer	2.26e-05	0.000312	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—KIT—germ cell cancer	2.25e-05	0.000311	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—FGFR3—germ cell cancer	2.23e-05	0.000308	CbGpPWpGaD
Loxapine—ADRA2B—Hemostasis—HRAS—germ cell cancer	2.22e-05	0.000306	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—KIT—germ cell cancer	2.2e-05	0.000304	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—KIT—germ cell cancer	2.17e-05	0.0003	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—TP53—germ cell cancer	2.17e-05	0.000299	CbGpPWpGaD
Loxapine—HRH2—Signaling by GPCR—HRAS—germ cell cancer	2.16e-05	0.000299	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—KITLG—germ cell cancer	2.16e-05	0.000298	CbGpPWpGaD
Loxapine—DRD5—Signaling by GPCR—HRAS—germ cell cancer	2.15e-05	0.000297	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—KIT—germ cell cancer	2.14e-05	0.000296	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—FGFR3—germ cell cancer	2.13e-05	0.000294	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—KITLG—germ cell cancer	2.13e-05	0.000294	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—KITLG—germ cell cancer	2.12e-05	0.000293	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—KITLG—germ cell cancer	2.11e-05	0.000292	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—AVP—germ cell cancer	2.11e-05	0.000292	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—KITLG—germ cell cancer	2.11e-05	0.000291	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—H2AFZ—germ cell cancer	2.1e-05	0.00029	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—MYC—germ cell cancer	2.1e-05	0.00029	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—FGFR3—germ cell cancer	2.1e-05	0.00029	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—KITLG—germ cell cancer	2.09e-05	0.000288	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—KITLG—germ cell cancer	2.08e-05	0.000287	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—AVP—germ cell cancer	2.08e-05	0.000287	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—AVP—germ cell cancer	2.07e-05	0.000286	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—HRAS—germ cell cancer	2.07e-05	0.000286	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—AVP—germ cell cancer	2.07e-05	0.000285	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AVP—germ cell cancer	2.06e-05	0.000284	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—KIT—germ cell cancer	2.05e-05	0.000283	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AVP—germ cell cancer	2.04e-05	0.000282	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AVP—germ cell cancer	2.03e-05	0.000281	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—KIT—germ cell cancer	1.95e-05	0.00027	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—KITLG—germ cell cancer	1.93e-05	0.000267	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—KIT—germ cell cancer	1.93e-05	0.000266	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—FGFR3—germ cell cancer	1.91e-05	0.000264	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—FGFR3—germ cell cancer	1.89e-05	0.000262	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AVP—germ cell cancer	1.89e-05	0.000261	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—FGFR3—germ cell cancer	1.83e-05	0.000253	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—MYC—germ cell cancer	1.83e-05	0.000252	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—FGFR3—germ cell cancer	1.82e-05	0.000251	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—FGFR3—germ cell cancer	1.77e-05	0.000244	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—TP53—germ cell cancer	1.76e-05	0.000243	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—KIT—germ cell cancer	1.76e-05	0.000242	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—FGFR3—germ cell cancer	1.74e-05	0.000241	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—KIT—germ cell cancer	1.74e-05	0.00024	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—TP53—germ cell cancer	1.72e-05	0.000238	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—HRAS—germ cell cancer	1.68e-05	0.000232	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—KIT—germ cell cancer	1.68e-05	0.000232	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—KIT—germ cell cancer	1.67e-05	0.000231	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—HRAS—germ cell cancer	1.66e-05	0.000229	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—HRAS—germ cell cancer	1.66e-05	0.000229	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—HRAS—germ cell cancer	1.65e-05	0.000228	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—HRAS—germ cell cancer	1.65e-05	0.000227	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—MYC—germ cell cancer	1.63e-05	0.000225	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—KIT—germ cell cancer	1.62e-05	0.000224	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—MYC—germ cell cancer	1.62e-05	0.000223	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—HRAS—germ cell cancer	1.61e-05	0.000223	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—FGFR3—germ cell cancer	1.61e-05	0.000222	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—KIT—germ cell cancer	1.6e-05	0.000221	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—HRAS—germ cell cancer	1.59e-05	0.000219	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—FGFR3—germ cell cancer	1.58e-05	0.000218	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—FGFR3—germ cell cancer	1.58e-05	0.000218	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—FGFR3—germ cell cancer	1.57e-05	0.000217	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—FGFR3—germ cell cancer	1.57e-05	0.000216	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—HRAS—germ cell cancer	1.57e-05	0.000216	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—FGFR3—germ cell cancer	1.55e-05	0.000214	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—FGFR3—germ cell cancer	1.55e-05	0.000214	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—TP53—germ cell cancer	1.5e-05	0.000207	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—HRAS—germ cell cancer	1.5e-05	0.000207	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—KIT—germ cell cancer	1.47e-05	0.000204	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—KIT—germ cell cancer	1.45e-05	0.0002	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—KIT—germ cell cancer	1.45e-05	0.0002	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—KIT—germ cell cancer	1.44e-05	0.000199	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—KIT—germ cell cancer	1.44e-05	0.000199	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—FGFR3—germ cell cancer	1.44e-05	0.000199	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—HRAS—germ cell cancer	1.44e-05	0.000198	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—HRAS—germ cell cancer	1.43e-05	0.000197	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—KIT—germ cell cancer	1.42e-05	0.000197	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—KIT—germ cell cancer	1.42e-05	0.000196	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—HRAS—germ cell cancer	1.41e-05	0.000195	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TP53—germ cell cancer	1.34e-05	0.000185	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TP53—germ cell cancer	1.33e-05	0.000183	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—KIT—germ cell cancer	1.32e-05	0.000182	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—HRAS—germ cell cancer	1.28e-05	0.000177	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—HRAS—germ cell cancer	1.28e-05	0.000177	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—HRAS—germ cell cancer	1.27e-05	0.000176	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—HRAS—germ cell cancer	1.27e-05	0.000175	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—MYC—germ cell cancer	1.25e-05	0.000172	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—MYC—germ cell cancer	1.25e-05	0.000172	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MYC—germ cell cancer	1.24e-05	0.000171	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—HRAS—germ cell cancer	1.23e-05	0.00017	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—HRAS—germ cell cancer	1.22e-05	0.000169	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MYC—germ cell cancer	1.21e-05	0.000167	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MYC—germ cell cancer	1.19e-05	0.000165	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—HRAS—germ cell cancer	1.19e-05	0.000164	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MYC—germ cell cancer	1.18e-05	0.000163	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—HRAS—germ cell cancer	1.17e-05	0.000162	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MYC—germ cell cancer	1.13e-05	0.000156	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—HRAS—germ cell cancer	1.08e-05	0.000149	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MYC—germ cell cancer	1.07e-05	0.000148	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—HRAS—germ cell cancer	1.06e-05	0.000147	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MYC—germ cell cancer	1.06e-05	0.000146	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—HRAS—germ cell cancer	1.06e-05	0.000146	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—HRAS—germ cell cancer	1.06e-05	0.000146	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—HRAS—germ cell cancer	1.05e-05	0.000145	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—HRAS—germ cell cancer	1.04e-05	0.000144	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—HRAS—germ cell cancer	1.04e-05	0.000143	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TP53—germ cell cancer	1.03e-05	0.000142	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TP53—germ cell cancer	1.02e-05	0.000141	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TP53—germ cell cancer	1.02e-05	0.00014	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TP53—germ cell cancer	9.96e-06	0.000138	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—HRAS—germ cell cancer	9.8e-06	0.000135	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TP53—germ cell cancer	9.8e-06	0.000135	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—HRAS—germ cell cancer	9.79e-06	0.000135	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—HRAS—germ cell cancer	9.73e-06	0.000134	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TP53—germ cell cancer	9.67e-06	0.000134	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MYC—germ cell cancer	9.66e-06	0.000133	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—HRAS—germ cell cancer	9.66e-06	0.000133	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MYC—germ cell cancer	9.57e-06	0.000132	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—HRAS—germ cell cancer	9.53e-06	0.000132	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—HRAS—germ cell cancer	9.37e-06	0.000129	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TP53—germ cell cancer	9.26e-06	0.000128	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—HRAS—germ cell cancer	9.25e-06	0.000128	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MYC—germ cell cancer	9.24e-06	0.000128	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MYC—germ cell cancer	9.19e-06	0.000127	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MYC—germ cell cancer	8.94e-06	0.000123	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—HRAS—germ cell cancer	8.86e-06	0.000122	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TP53—germ cell cancer	8.82e-06	0.000122	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MYC—germ cell cancer	8.8e-06	0.000122	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TP53—germ cell cancer	8.71e-06	0.00012	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—HRAS—germ cell cancer	8.44e-06	0.000117	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—HRAS—germ cell cancer	8.33e-06	0.000115	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MYC—germ cell cancer	8.11e-06	0.000112	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MYC—germ cell cancer	7.98e-06	0.00011	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MYC—germ cell cancer	7.97e-06	0.00011	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MYC—germ cell cancer	7.94e-06	0.00011	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TP53—germ cell cancer	7.93e-06	0.00011	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MYC—germ cell cancer	7.91e-06	0.000109	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TP53—germ cell cancer	7.86e-06	0.000109	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MYC—germ cell cancer	7.84e-06	0.000108	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MYC—germ cell cancer	7.82e-06	0.000108	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TP53—germ cell cancer	7.59e-06	0.000105	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—HRAS—germ cell cancer	7.59e-06	0.000105	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TP53—germ cell cancer	7.55e-06	0.000104	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—HRAS—germ cell cancer	7.52e-06	0.000104	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TP53—germ cell cancer	7.34e-06	0.000101	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MYC—germ cell cancer	7.26e-06	0.0001	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—HRAS—germ cell cancer	7.26e-06	0.0001	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TP53—germ cell cancer	7.23e-06	9.98e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—HRAS—germ cell cancer	7.22e-06	9.97e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—HRAS—germ cell cancer	7.02e-06	9.7e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—HRAS—germ cell cancer	6.91e-06	9.54e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TP53—germ cell cancer	6.66e-06	9.2e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TP53—germ cell cancer	6.56e-06	9.05e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TP53—germ cell cancer	6.54e-06	9.03e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TP53—germ cell cancer	6.52e-06	9e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TP53—germ cell cancer	6.5e-06	8.98e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TP53—germ cell cancer	6.44e-06	8.89e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TP53—germ cell cancer	6.42e-06	8.86e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—HRAS—germ cell cancer	6.37e-06	8.8e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—HRAS—germ cell cancer	6.27e-06	8.66e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—HRAS—germ cell cancer	6.26e-06	8.64e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—HRAS—germ cell cancer	6.24e-06	8.61e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—HRAS—germ cell cancer	6.22e-06	8.58e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—HRAS—germ cell cancer	6.16e-06	8.5e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—HRAS—germ cell cancer	6.14e-06	8.48e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TP53—germ cell cancer	5.96e-06	8.24e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—HRAS—germ cell cancer	5.7e-06	7.88e-05	CbGpPWpGaD
